These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21136248)

  • 1. Internalization of biotinylated compounds into cancer cells is promoted by a molecular Trojan horse based upon core streptavidin and clostridial C2 toxin.
    Fahrer J; Funk J; Lillich M; Barth H
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):263-73. PubMed ID: 21136248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetically engineered clostridial C2 toxin as a novel delivery system for living mammalian cells.
    Fahrer J; Plunien R; Binder U; Langer T; Seliger H; Barth H
    Bioconjug Chem; 2010 Jan; 21(1):130-9. PubMed ID: 20030334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular uptake of Clostridium botulinum C2 toxin: membrane translocation of a fusion toxin requires unfolding of its dihydrofolate reductase domain.
    Haug G; Wilde C; Leemhuis J; Meyer DK; Aktories K; Barth H
    Biochemistry; 2003 Dec; 42(51):15284-91. PubMed ID: 14690438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The binary Clostridium botulinum C2 toxin as a protein delivery system: identification of the minimal protein region necessary for interaction of toxin components.
    Barth H; Roebling R; Fritz M; Aktories K
    J Biol Chem; 2002 Feb; 277(7):5074-81. PubMed ID: 11741886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium botulinum C2 toxin: low pH-induced pore formation is required for translocation of the enzyme component C2I into the cytosol of host cells.
    Blöcker D; Pohlmann K; Haug G; Bachmeyer C; Benz R; Aktories K; Barth H
    J Biol Chem; 2003 Sep; 278(39):37360-7. PubMed ID: 12869543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C2-streptavidin delivery system promotes the uptake of biotinylated molecules in macrophages and T-leukemia cells.
    Fahrer J; Rieger J; van Zandbergen G; Barth H
    Biol Chem; 2010 Nov; 391(11):1315-25. PubMed ID: 20868225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal part of the enzyme component (C2I) of the binary Clostridium botulinum C2 toxin interacts with the binding component C2II and functions as a carrier system for a Rho ADP-ribosylating C3-like fusion toxin.
    Barth H; Hofmann F; Olenik C; Just I; Aktories K
    Infect Immun; 1998 Apr; 66(4):1364-9. PubMed ID: 9529054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The host cell chaperone Hsp90 is essential for translocation of the binary Clostridium botulinum C2 toxin into the cytosol.
    Haug G; Leemhuis J; Tiemann D; Meyer DK; Aktories K; Barth H
    J Biol Chem; 2003 Aug; 278(34):32266-74. PubMed ID: 12805360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell-permeable fusion protein based on Clostridium botulinum C2 toxin for delivery of p53 tumorsuppressor into cancer cells.
    Fahrer J; Rausch J; Barth H
    PLoS One; 2013; 8(9):e72455. PubMed ID: 24039769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Channel formation by the binding component of Clostridium botulinum C2 toxin: glutamate 307 of C2II affects channel properties in vitro and pH-dependent C2I translocation in vivo.
    Blöcker D; Bachmeyer C; Benz R; Aktories K; Barth H
    Biochemistry; 2003 May; 42(18):5368-77. PubMed ID: 12731878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK506-binding protein 51 interacts with Clostridium botulinum C2 toxin and FK506 inhibits membrane translocation of the toxin in mammalian cells.
    Kaiser E; Böhm N; Ernst K; Langer S; Schwan C; Aktories K; Popoff M; Fischer G; Barth H
    Cell Microbiol; 2012 Aug; 14(8):1193-205. PubMed ID: 22420783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular trafficking of Clostridium botulinum C2 toxin.
    Nagahama M; Takahashi C; Aoyanagi K; Tashiro R; Kobayashi K; Sakaguchi Y; Ishidoh K; Sakurai J
    Toxicon; 2014 May; 82():76-82. PubMed ID: 24582943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophilin A facilitates translocation of the Clostridium botulinum C2 toxin across membranes of acidified endosomes into the cytosol of mammalian cells.
    Kaiser E; Pust S; Kroll C; Barth H
    Cell Microbiol; 2009 May; 11(5):780-95. PubMed ID: 19159389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell-permeable fusion toxin as a tool to study the consequences of actin-ADP-ribosylation caused by the salmonella enterica virulence factor SpvB in intact cells.
    Pust S; Hochmann H; Kaiser E; von Figura G; Heine K; Aktories K; Barth H
    J Biol Chem; 2007 Apr; 282(14):10272-82. PubMed ID: 17283073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The
    Heber S; Borho J; Stadler N; Wondany F; König I; Michaelis J; Papatheodorou P; Barth H; Fellermann M
    Toxins (Basel); 2023 Jun; 15(6):. PubMed ID: 37368691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of a biologically active toxin complex of the binary Clostridium botulinum C2 toxin without cell membrane interaction.
    Kaiser E; Haug G; Hliscs M; Aktories K; Barth H
    Biochemistry; 2006 Nov; 45(44):13361-8. PubMed ID: 17073457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C2-streptavidin mediates the delivery of biotin-conjugated tumor suppressor protein p53 into tumor cells.
    Fahrer J; Schweitzer B; Fiedler K; Langer T; Gierschik P; Barth H
    Bioconjug Chem; 2013 Apr; 24(4):595-603. PubMed ID: 23506195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding and internalization of Clostridium botulinum C2 toxin.
    Nagahama M; Hagiyama T; Kojima T; Aoyanagi K; Takahashi C; Oda M; Sakaguchi Y; Oguma K; Sakurai J
    Infect Immun; 2009 Nov; 77(11):5139-48. PubMed ID: 19720757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clostridium botulinum C2 toxin: binding studies with fluorescence-activated cytometry.
    Stiles BG; Blöcker D; Hale ML; Guetthoff MA; Barth H
    Toxicon; 2002 Aug; 40(8):1135-140. PubMed ID: 12165316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined Pharmacological Inhibition of Cyclophilins, FK506-Binding Proteins, Hsp90, and Hsp70 Protects Cells From
    Ernst K; Kling C; Landenberger M; Barth H
    Front Pharmacol; 2018; 9():1287. PubMed ID: 30483129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.